
One-Hour Brush Test Flags Early Oral Cancer with 95% Accuracy
Researchers tested qMIDS, a painless brush-swab test that analyzes four cancer-linked gene mRNA (plus a control sample) to distinguish oral cancer from benign lesions. In 545 patients, the test achieved 95.5% overall accuracy with false-positive/false-negative rates under 5%, delivering results in about an hour. This non-invasive method could reduce the need for biopsies and enable repeated monitoring, with commercialization anticipated within two years and the study published in Biomarker Research (2026).













